On June 14, 2021 Eli Lilly and Company (NYSE: LLY) reported that it will participate in the Guggenheim Biopharma Strategy Series – Biopharma’s Next Decade: Views from the Top on Global Strategy and Innovation – on Friday, June 18, 2021 (Press release, Eli Lilly, JUN 14, 2021, View Source [SID1234583945]). Daniel Skovronsky, M.D., Ph.D., Lilly’s Chief Scientific and Medical Officer and President of Lilly Research Laboratories, will participate in a virtual fireside chat at 11:00 a.m., Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly’s Investor website at View Source A replay of the presentation will be available on this same website for approximately 90 days.